CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 506.1% in November

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 59,400 shares, a growth of 506.1% from the October 31st total of 9,800 shares. Based on an average daily trading volume, of 484,300 shares, the short-interest ratio is presently 0.1 days.

CV Sciences Price Performance

Shares of CVSI remained flat at $0.04 during mid-day trading on Friday. 79,254 shares of the stock traded hands, compared to its average volume of 206,762. CV Sciences has a twelve month low of $0.03 and a twelve month high of $0.10. The stock has a market cap of $7.37 million, a price-to-earnings ratio of -3.99 and a beta of 0.59. The company has a fifty day simple moving average of $0.05 and a 200 day simple moving average of $0.05.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.